Evidence map›Paper›PMID 8657119›Full record

ArticleMolecular and cellular biology1996

Raf, but not MEK or ERK, is sufficient for differentiation of hippocampal neuronal cells.

W L Kuo, M Abe, J Rhee, E M Eves, S A McCarthy, M Yan, D J Templeton, M McMahon, M R Rosner

Open access · hybridAbstract read
In one paragraph

Article in Molecular and cellular biology, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 87 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Vitamin D and differentiation in cancer.Critical reviews in clinical laboratory sciences · 2009
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Raf-1 promotes cell survival by antagonizing apoptosis signal-regulating kinase 1 through a MEK-ERK independent mechanism.Proceedings of the National Academy of Sciences of the United States of America · 2001
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

W L KuoBen May Institute, University of Chicago, Ilinois 60637, USA.
M Abe
J Rhee
E M Eves
S A McCarthy
M Yan
D J Templeton
M McMahon
M R Rosner
University of Chicago · USUniversity School · US

Funding

MODULATION OF CELLULAR PHOSPHORYLATION BY TUMOR PROMOTERR01CA035541 · NCI · UNIVERSITY OF CHICAGO · PI ROSNER, MARSHA R · 1985 to 1995
–
NCI NIH HHS CA 35541NCI NIH HHS CA 40042
6 · The paper itself

Abstract

To elucidate signal transduction pathways leading to neuronal differentiation, we have investigated a conditionally immortalized cell line from rat hippocampal neurons (H19-7) that express a temperature sensitive simian virus 40 large T antigen. Treatment of H19-7 cells with the differentiating agent basic fibroblast growth factor at 39 degrees C, the nonpermissive temperature for T function, resulted in the activation of c-Raf-1, MEK, and mitogen-activated protein (MAP) kinases (ERK1 and -2). To evaluate the role of Raf-1 in neuronal cell differentiation, we stably transfected H19-7 cells with v-raf or an oncogenic human Raf-1-estrogen receptor fusion gene (deltaRaf-1:ER). deltaRaf-1:ER transfectants in the presence of estradiol for 1 to 2 days expressed a differentiation phenotype only at the nonpermissive temperature. However, extended exposure of the deltaRaf-1:ER transfectants to estradiol or stable expression of the v-raf construct yielded cells that extended processes at the permissive as well as the nonpermissive temperature, suggesting that cells expressing the large T antigen are capable of responding to the Raf differentiation signal. deltaRaf-1:ER, MEK, and MAP kinase activities in the deltaRaf-1:ER cells were elevated constitutively for up to 36 h of estradiol treatment at the permissive temperature. At the nonpermissive temperature, MEK and ERKs were activated to a significantly lesser extent, suggesting that prolonged MAP kinase activation may not be sufficient for differentiation. To test this possibility, H19-7 cells were transfected or microinjected with constitutively activated MEK. The results indicate that prolonged activation of MEK or MAP kinases (ERK1 and -2) is not sufficient for differentiation of H19-7 neuronal cells and raise the possibility that an alternative signaling pathway is required for differentiation of H19-7 cells by Raf.

Indexed as

MAP Kinase Kinase Kinase 1Mitogen-Activated Protein KinasesAnimalsAntigens, Polyomavirus TransformingCalcium-Calmodulin-Dependent Protein KinasesCell DifferentiationCell LineEstradiolFibroblast Growth Factor 2HippocampusHumansMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3NeuronsOncogene Proteins v-rafPhosphorylationAntigens, Polyomavirus TransformingCalcium-Calmodulin-Dependent Protein KinasesEstradiolFibroblast Growth Factor 2MAP3K1 protein, humanMAP Kinase Kinase Kinase 1Mitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Mitogen-Activated Protein KinasesOncogene Proteins v-rafProtein Serine-Threonine KinasesReceptors, EstrogenRecombinant Fusion ProteinsRetroviridae Proteins, Oncogenic

Identifiers

PMID8657119
PMCPMC231130
OpenAlexW2166306472

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.